| Market Research A to Z | Company Profiles A to Z | Register | Contact Us |
| +44 (0) 203 086 8600 Call us on |
United Arab Emirates Pharmaceuticals and Healthcare Report Q1 2010
Market |
Healthcare and Medical |
Report Type |
Market Research |
Country |
United Arab Emirates |
Published |
15 December 2009 |
Number of Pages |
96 |
Download |
|
Immediate |
|
Publisher |
Business Monitor International |
In November 2009 the UAE government announced that an independent federal authority will be established to regulate the quality and safety of food and drugs entering the country. It is believed that the successful implementation of this body – essentially a UAE version of the US Food and Drug Administration (FDA) – will be attractive to multinational drugmakers operating in the country.
We expect the total drug market to increase in value from US$1.31bn in 2008 to US$1.5bn by 2009. Thereafter, we expect the drug market to reach US$2.65bn by 2014, representing a compound annual growth rate (CAGR) of 21% in US dollar terms. Our extended 10-year forecast indicates that the market will reach US$3.4bn by 2019, showing a slow CAGR of 5.2% from 2014 onwards. We believe that as the second largest pharmaceutical market in the Gulf Co-operation Council (GCC) region after Saudi Arabia, the UAE’s introduction of a proper regulatory body is a wise move. Saudi Arabia already has the SFDA, which affiliates testing laboratories for drugs and food products. We note that recently the fluctuations in medicine prices in the UAE have led to greater pressure on the government to import and manufacture more generic drugs. This is yet to happen due to the lack of testing facilities in the country. Bioequivalence and other quality control analyses are not consistently carried out for foreign medicines entering the UAE. Instead, medicines come from the EU or US where strict regulations are already in force.
Healthcare sector advertising in the GCC region during January-September 2009 was worth approximately US$162mn, according to the findings of UAE-based research group the Pan Arab Research Centre. The group has revealed that total 2009 spending on advertising for the industry could reach US$215mn. It is believed that since the member states of the GCC are undergoing healthcare reform or promoting medical tourism (in the more developed countries), the increased spending on advertising is to be expected.
The creation of the Healthcare City (HC) in Dubai has yet to fulfil its potential for attracting international patients. It is believed the Dubai government has to promote its medical tourism benefits more widely in order to gain considerably from its substantial investment.
At present, the HC has 80 English-speaking clinics, with highly qualified doctors, cheaper prices per procedure than the US, no waiting times and the close proximity of holiday areas already renowned for luxury and relaxation. Construction of the second phase of the HC’s complex will include spas and other ‘wellness’ facilities. The completed complex will form the largest medical tourism centre between Asia and Europe.
Last Viewed
United Arab Emirates Pharmaceuticals and Healthcare Report Q1 2010Toppan Printing Co., Ltd. - Financial and Strategic Analysis Review
Nippon Paper Group, Inc. - Financial and Strategic Analysis Review
Utilities in the downturn - strategic responses in B2B energy markets
High Speed Steel (HSS) Metal Cutting Tools - A World Market Analysis
Healthcare and Medical Company Profiles
Healthcare and Medical Company Profiles contain up to date financial, strategic, operational, SWOT analysis and product information on the activities of thousands of healthcare and medical companies.
Become an Affiliate
Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?
Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).
Custom Research
Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.
News
Genium Bionic Prosthetic System Represents the First Intuitive Knee
AdCare continues nursing facilities acquisitions strategy
AdCare Purchases US$27.3Mn Nursing Facilities in Arkansas to Drive Strong Revenue Growth
Micromet to Develop Blinatumomab with the National Cancer Institute
AstraZeneca to Develop Targacept’s Product Candidate AZD1446 as a Treatment for Alzheimer’s
Market Insights
Currently there are no Market Insights in this sector.
